Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Seyhan Boyoglu-Barnum

Dr. Seyhan Boyoglu-Barnum

Scientific Review Officer



Biography

Division:
Division of Physiological and Pathological Sciences – DPPS
Review Branch:
Immunology and Infectious Diseases A – IIDA

Dr. Seyhan Boyoglu-Barnum earned her Ph.D. from Alabama State University and completed postdoctoral training at Emory University, where she specialized in respiratory syncytial virus (RSV) vaccine development. She contributed to the MERS outbreak response within the CDC’s Division of Viral Diseases before joining the NIH Vaccine Research Center (VRC) in 2016. At VRC, Dr. Boyoglu-Barnum led mosaic influenza vaccine research and preclinical studies supporting the COVID-19 pandemic response. Dr. Boyoglu-Barnum has served as an editor for multiple immunology and virology journals, authored forty-eight peer-reviewed publications, and is a patent holder. Prior to joining CSR, she served as senior manager and acting director at GlaxoSmithKline (GSK), where she led U.S. scientific communications and supported viral vaccine research and development.

 

Last updated: 01/22/2026 12:34